Minran Huang

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

SH3BGRL2 as a vital tumor suppressor and prognostic factor in human esophageal squamous cell carcinoma.

SH3BGRL2 as a vital tumor suppressor and prognostic factor in human esophageal squamous cell carcinoma.

Journal: Journal of thoracic disease

Published: September 12, 2025

Establishment and characterization of preclinical model of primary ovarian squamous cell carcinoma.

Establishment and characterization of preclinical model of primary ovarian squamous cell carcinoma.

Journal: Human cell

Published: December 20, 2024

Tumor microenvironment biomarkers predicting pathological response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma: post-hoc analysis of a single center, phase 2 study.

Tumor microenvironment biomarkers predicting pathological response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma: post-hoc analysis of a single center, phase 2 study.

Journal: Journal for immunotherapy of cancer

Published: August 09, 2024

A predictive model for prognostic risk stratification of early-stage NSCLC based on clinicopathological and miRNA panel.

A predictive model for prognostic risk stratification of early-stage NSCLC based on clinicopathological and miRNA panel.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 28, 2023

Immune-active tumor-adjacent tissues are associated with favorable prognosis in stage I lung squamous cell carcinoma.

Immune-active tumor-adjacent tissues are associated with favorable prognosis in stage I lung squamous cell carcinoma.

Journal: iScience

Published: March 05, 2023

Oncogenic Alterations in Histologically Negative Lymph Nodes Are Associated with Prognosis of Patients with Stage I Lung Adenocarcinoma.

Oncogenic Alterations in Histologically Negative Lymph Nodes Are Associated with Prognosis of Patients with Stage I Lung Adenocarcinoma.

Journal: Cancers

Published: December 19, 2021

Development of a serum miRNA panel for detection of early stage non-small cell lung cancer.

Development of a serum miRNA panel for detection of early stage non-small cell lung cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 18, 2020

Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma.

Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma.

Journal: Annals of translational medicine

Published: May 02, 2020

A Nomogram to Predict the Pathologic Complete Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Based on Simple Laboratory Indicators.

A Nomogram to Predict the Pathologic Complete Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Based on Simple Laboratory Indicators.

Journal: Annals of surgical oncology

Published: April 14, 2019

Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma.

Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma.

Journal: Nature communications

Published: December 27, 2018

GAP43, a novel metastasis promoter in non-small cell lung cancer.

GAP43, a novel metastasis promoter in non-small cell lung cancer.

Journal: Journal of translational medicine

Published: August 27, 2018

Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer.

Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer.

Journal: Molecular cancer research : MCR

Published: August 31, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026